Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer - PubMed (original) (raw)
Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer
M Toi et al. Jpn J Cancer Res. 1994 Oct.
Abstract
Angiogenesis is an independent prognostic indicator in breast cancer. In this report, the relationship between expression of vascular endothelial growth factor (VEGF; a selective mitogen for endothelial cells) and the microvessel density was examined in 103 primary breast cancers. The expression of VEGF was evaluated by immunocytochemical staining using anti-VEGF antibody. The microvessel density, which was determined by immunostaining for factor VIII antigen, in VEGF-rich tumors was clearly higher than that in VEGF-poor tumors (P < 0.01). There was a good correlation between VEGF expression and the increment of microvessel density. Furthermore, postoperative survey demonstrated that the relapse-free survival rate of VEGF-rich tumors was significantly worse than that of VEGF-poor tumors. It was suggested that the expression of VEGF is closely associated with the promotion of angiogenesis and with early relapse in primary breast cancer.
Similar articles
- Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression.
Toi M, Inada K, Suzuki H, Tominaga T. Toi M, et al. Breast Cancer Res Treat. 1995;36(2):193-204. doi: 10.1007/BF00666040. Breast Cancer Res Treat. 1995. PMID: 8534867 - Immunohistochemical measurement of tumor vascular endothelial growth factor in breast cancer. A more reliable predictor of tumor stage than microvessel density or serum vascular endothelial growth factor.
Callagy G, Dimitriadis E, Harmey J, Bouchier-Hayes D, Leader M, Kay E. Callagy G, et al. Appl Immunohistochem Mol Morphol. 2000 Jun;8(2):104-9. doi: 10.1097/00129039-200006000-00004. Appl Immunohistochem Mol Morphol. 2000. PMID: 10937057 - Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer.
Yuan A, Yu CJ, Chen WJ, Lin FY, Kuo SH, Luh KT, Yang PC. Yuan A, et al. Int J Cancer. 2000 Nov 20;89(6):475-83. doi: 10.1002/1097-0215(20001120)89:6<475::aid-ijc2>3.0.co;2-t. Int J Cancer. 2000. PMID: 11102890 - Prognostic value of vascular endothelial growth factor in breast cancer.
Gasparini G. Gasparini G. Oncologist. 2000;5 Suppl 1:37-44. doi: 10.1634/theoncologist.5-suppl_1-37. Oncologist. 2000. PMID: 10804090 Review. - The predictive value of angiogenesis for adjuvant therapy in breast cancer.
Toi M, Bando H, Kuroi K. Toi M, et al. Breast Cancer. 2000;7(4):311-4. doi: 10.1007/BF02966396. Breast Cancer. 2000. PMID: 11114856 Review.
Cited by
- Evaluating the effect of Avastin on breast cancer angiogenesis using synchrotron radiation.
Gu S, Xue J, Xi Y, Tang R, Jin W, Chen JJ, Zhang X, Shao ZM, Wu J. Gu S, et al. Quant Imaging Med Surg. 2019 Mar;9(3):418-426. doi: 10.21037/qims.2019.03.09. Quant Imaging Med Surg. 2019. PMID: 31032189 Free PMC article. - Ultrasound-targeted microbubble destruction improved the antiangiogenic effect of Endostar in triple-negative breast carcinoma xenografts.
Jing Y, Xiu-Juan Z, Hong-Jiao C, Zhi-Kui C, Qing-Fu Q, En-Sheng X, Li-Wu L. Jing Y, et al. J Cancer Res Clin Oncol. 2019 May;145(5):1191-1200. doi: 10.1007/s00432-019-02866-7. Epub 2019 Feb 25. J Cancer Res Clin Oncol. 2019. PMID: 30805775 - Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E.
Scott PA, Smith K, Poulsom R, De Benedetti A, Bicknell R, Harris AL. Scott PA, et al. Br J Cancer. 1998 Jun;77(12):2120-8. doi: 10.1038/bjc.1998.356. Br J Cancer. 1998. PMID: 9649123 Free PMC article. - Mesenchymal stem cells and cancer therapy: insights into targeting the tumour vasculature.
Aravindhan S, Ejam SS, Lafta MH, Markov A, Yumashev AV, Ahmadi M. Aravindhan S, et al. Cancer Cell Int. 2021 Mar 8;21(1):158. doi: 10.1186/s12935-021-01836-9. Cancer Cell Int. 2021. PMID: 33685452 Free PMC article. Review.
References
- ) Folkman , J. , Watson , K. , Ingber , D. and Hanahan , D.Induction of angiogenesis during the transition from hyperplasia to neoplasia . Nature , 339 , 58 – 61 ( 1989. ). - PubMed
- ) Bicknell , R. and Harris , A. L.Novel growth regulatory factors and tumor angiogenesis . Eur. J. Cancer , 27 , 781 – 784 ( 1991. ). - PubMed
- ) Weidner , N. , Folkman , J. , Pozza , F. , Bevilacqua , P. , Allied , E. N. , Moore , D. H. , Meli , S. and Gasparini , G.Tumor angiogenesis: a new significant and independent prognostic indicator in early‐stage breast carcinoma . J. Natl. Cancer Inst. , 84 , 1875 – 1887 ( 1992. ). - PubMed
- ) Horak , E. R. , Leek , R. , Klenk , N. , Lejeune , S. , Smith , K. , Stuart , N. , Greenall , M. , Stepniewska , K. and Harris , A. L.Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer . Lancet , 340 , 1120 – 1124 ( 1992. ). - PubMed
- ) Bosari , S. , Lee , A. K. C. , DeLellis , R. A. , Wiley , B. D. , Heatley , G. J. and Silverman , M. L.Microvessel quantitation and prognosis in invasive breast carcinoma . Hum. Pathol. , 23 , 755 – 761 ( 1992. ). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical